The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

though benefits appear across all age groups. The medications demonstrate effectiveness regardless of diabetes duration, though earlier intervention correlates with better outcomes. SGLT-2 ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Also, the Nature Medicine study focuses on patients with a very specific profile, generally older men, supposedly all diabetic. It is therefore impossible at this stage to generalise its conclusions.

All study participants had a starting body mass index (BMI) greater than 25, and were not taking any diabetes medications other than metformin. Scientists randomly assigned participants into two ...

“We have all these weight-loss drugs that definitely ... It also stimulates the pancreas to produce insulin. Drugs like Ozempic and Wegovy replicate this process. “It tells my brain I ...

If you have diabetes, it's crucial to watch your diet and choose your drinks wisely. While teas might seem like a healthy ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...